Arecor Therapeutics Statistics
Total Valuation
AIM:AREC has a market cap or net worth of GBP 31.72 million. The enterprise value is 30.00 million.
Market Cap | 31.72M |
Enterprise Value | 30.00M |
Important Dates
The last earnings date was Thursday, September 11, 2025.
Earnings Date | Sep 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
AIM:AREC has 37.76 million shares outstanding. The number of shares has increased by 20.83% in one year.
Current Share Class | 37.76M |
Shares Outstanding | 37.76M |
Shares Change (YoY) | +20.83% |
Shares Change (QoQ) | +4.15% |
Owned by Insiders (%) | 12.13% |
Owned by Institutions (%) | 51.14% |
Float | 22.71M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 6.27 |
PB Ratio | 11.10 |
P/TBV Ratio | 11.20 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.70 |
EV / Sales | 5.93 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -4.82 |
Financial Position
The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.06.
Current Ratio | 2.05 |
Quick Ratio | 2.00 |
Debt / Equity | 0.06 |
Debt / EBITDA | n/a |
Debt / FCF | -0.03 |
Interest Coverage | -308.06 |
Financial Efficiency
Return on equity (ROE) is -204.29% and return on invested capital (ROIC) is -82.64%.
Return on Equity (ROE) | -204.29% |
Return on Assets (ROA) | -44.39% |
Return on Invested Capital (ROIC) | -82.64% |
Return on Capital Employed (ROCE) | -189.64% |
Revenue Per Employee | 115,023 |
Profits Per Employee | -184,182 |
Employee Count | 44 |
Asset Turnover | 0.65 |
Inventory Turnover | 12.39 |
Taxes
Income Tax | -265,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.44% in the last 52 weeks. The beta is -0.28, so AIM:AREC's price volatility has been lower than the market average.
Beta (5Y) | -0.28 |
52-Week Price Change | +24.44% |
50-Day Moving Average | 68.60 |
200-Day Moving Average | 54.13 |
Relative Strength Index (RSI) | 81.11 |
Average Volume (20 Days) | 37,449 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AIM:AREC had revenue of GBP 5.06 million and -8.10 million in losses. Loss per share was -0.22.
Revenue | 5.06M |
Gross Profit | 1.60M |
Operating Income | -5.55M |
Pretax Income | -8.37M |
Net Income | -8.10M |
EBITDA | -5.35M |
EBIT | -5.55M |
Loss Per Share | -0.22 |
Balance Sheet
The company has 1.89 million in cash and 173,000 in debt, giving a net cash position of 1.71 million or 0.05 per share.
Cash & Cash Equivalents | 1.89M |
Total Debt | 173,000 |
Net Cash | 1.71M |
Net Cash Per Share | 0.05 |
Equity (Book Value) | 2.86M |
Book Value Per Share | 0.08 |
Working Capital | 2.45M |
Cash Flow
In the last 12 months, operating cash flow was -6.12 million and capital expenditures -106,000, giving a free cash flow of -6.22 million.
Operating Cash Flow | -6.12M |
Capital Expenditures | -106,000 |
Free Cash Flow | -6.22M |
FCF Per Share | -0.16 |
Margins
Gross margin is 31.67%, with operating and profit margins of -109.56% and -160.13%.
Gross Margin | 31.67% |
Operating Margin | -109.56% |
Pretax Margin | -165.36% |
Profit Margin | -160.13% |
EBITDA Margin | -105.65% |
EBIT Margin | -109.56% |
FCF Margin | n/a |
Dividends & Yields
AIM:AREC does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -20.83% |
Shareholder Yield | n/a |
Earnings Yield | -25.55% |
FCF Yield | -19.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
AIM:AREC has an Altman Z-Score of -8.54 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -8.54 |
Piotroski F-Score | 4 |